Systematic review protocol: following PRISMA guide from Cochrane to generate evidence as treatment effect of pharmaceutical care for hypertension in primary care

Autor(es)

Cazarim, Maurilio de Souza ^{[1, 2]} ; dos Reis, Tiago Marques ^[3] ; Coelho da Cruz-Cazarim, Estael Luzia ^[4] ; Leira Pereira, Leonardo Regis ^[5]

Afiliação do(s) autor(es)

^[1] Univ Sao Paulo, Pharmaceut Serv & Clin Pharm Res Ctr CPAFF, Sch Pharmaceut Sci Ribeirao Preto, PhD Pharmaceut Sci Dept, Ribeirao Preto, SP - Brazil

^[2] Univ Fed Juiz de Fora, Fac Farmacy, Juiz De Fora, MG - Brazil

^[3] Univ Fed Alfenas, Fac Pharmaceut Sci, Alfenas, MG - Brazil

^[4] Univ Sao Paulo, Sch Pharmaceut Sci Ribeirao Preto, Pharmaceut Serv, Ribeirao Preto, SP - Brazil

^[5] Univ Sao Paulo, Pharmaceut Serv & Clin Pharm Res Ctr CPAFF, Sch Pharmaceut Sci Ribeirao Preto, Dept Pharmaceut Sci Dept, Ribeirao Preto, SP - Brazil

• Tipo de documento: Artigo Científico
• Fonte: Brazilian Journal of Pharmaceutical Sciences; v. 56, 2020.
• Citações Web of Science: 0

Resumo

Pharmaceutical care (PC) is in the implementation process in Brazil and Latin America. Synthesis of evidence has been requested for monitoring and evaluating the process regarding the treatment effect. The objective is to build and disseminate a systematic review protocol to make a standard for updating results from pharmaceutical care for hypertension and for other diseases. This is a protocol for systematic review studies regarding a real example of a protocol reasoned in pharmaceutical care for hypertension in primary care. This protocol was delineated grounded in the Cochrane Handbook. Descriptors and words were defined using MeSH (Medical Subject Headings), DeCS (Descriptors in Health Sciences) and Emtree thesaurus, and the search was performed in English, Spanish and Portuguese, without filters, up to March, 27th, 2017. The results were structured in the PRISMA flowchart. Results found from all databases were: the Cochrane Library (n= 202); PubMed (n= 2608); LILACs (n= 909); Embase (n= 1653); Scopus (n=1298); IPA (n=967); and Web of Sciences (n=435). From these, 1688 were duplicate articles. The content of this paper can aid the constant monitoring of pharmaceutical care implementation and contribute to the improvement of the quality and evidence levels of published studies. (AU)

• Processo FAPESP: 17/21240-0 - Desenvolvimento e validação de uma ferramenta farmacoeconômica para tomada de decisão na implantação da atenção farmacêutica para pacientes hipertensos no sistema de saúde público
• Beneficiário: Maurilio de Souza Cazarim
• Modalidade de apoio: Bolsas no Exterior - Estágio de Pesquisa - Doutorado
• Processo FAPESP: 16/03584-1 - Desenvolvimento e validação de uma ferramenta farmacoeconômica para a implantação da atenção farmacêutica para pacientes hipertensos no sistema público de saúde do brasil
• Beneficiário: Maurilio de Souza Cazarim
• Modalidade de apoio: Bolsas no Brasil - Doutorado